Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Pfizer/BioNTech COVID-19 vaccine produces strong immune response in children

A third dose of the vaccine has been trialled in children aged from six months to under five years old

- PMLiVE

AbbVie submits Parkinson’s disease therapy to FDA

The therapy offers a first-of-its-kind, 24-hour, continuous subcutaneous delivery

- PMLiVE

Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment

Dupixent is the first and only drug specifically recommended for EoE in the US

- PMLiVE

AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster

Vaxzevria is a ‘viral vector’ vaccine, a technology that is also used to create vaccines for other infectious diseases like flu, HIV and Ebola

- PMLiVE

Positive CHMP opinion issued for PTC Therapeutics’ Upstaza

The treatment for AADC will be the first marketed gene therapy to be administered directly into the brain

- PMLiVE

Medscape: Connect to the conversation

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. We are the largest medical education provider, delivering precision education for actionable outcomes across 30+ specialties in...

Medscape Education

- PMLiVE

A Medscape 4-part video interview series

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. We are the largest medical education provider, delivering precision education for actionable outcomes across 30+ specialties in...

Medscape Education

Why big pharma needs to be braver

The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...

Page & Page Health

EU flag

EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine

The vaccine is currently the only inactivated, whole virus adjuvanted candidate in clinical trials in Europe

- PMLiVE

UICC launches global ATOM Coalition to increase access to essential cancer medicines

If left unmonitored, deaths from cancer in poorer countries could rise to four million by 2040

Innovative Medical Solutions for Postponing and Undoing Age-Related Disease

Aubrey de Grey, Chief Science Officer at SENS Research Foundation, discusses a range of interesting topics surrounding innovative interventions and technologies that could not just postpone, but theoretically reverse, age-related...

Impetus Digital

- PMLiVE

Almirall and Evotec team up in multi-target dermatology alliance

The companies will focus on developing novel therapies for chronic skin diseases and skin cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links